Here at Omnicell, we are entering 2025 with a renewed ... with the addition of XT Cabinet automation and the expansion of anesthesia dispensing automation and software in order to support care ...

In the latest quarter, 4 analysts provided ratings for Omnicell (NASDAQ:OMCL), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect. Omnicell beat analysts’ revenue expectations by 0.6% last quarter, reporting ...

Omnicell, Inc. (NASDAQ:OMCL – Free Report) – Stock analysts at Zacks Research raised their Q2 2025 earnings per share (EPS) estimates for Omnicell in a report released on Tuesday, January 28th.

The Fifth Circuit Court of Appeals has upheld the dismissal of U.S. Anesthesia Partners' (lawsuit against the Department of HHS and CMS, which contested aspects of the Merit-based Incentive Payment ...

2-Year U.S. Treasury Note Continuous Contract $102.723-0.141-0.14% 5-Year U.S. Treasury Note Continuous Contract $106.461-0.273-0.26% 10-Year U.S. Treasury Note Continuous Contract $109.219-0.359 ...

If you’re on the fence about investing in Omnicell, Inc. or LivaNova PLC because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision. Read ...